Anaïs Le Rhun

Anaïs Le Rhun

Auto-generated profile, based on publicly available information

Anaïs Le Rhun

Univ. Bordeaux, CNRS, INSERM, ARNA, UMR 5320, U1212, F-33000 Bordeaux, France

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2016 in Nature
Verified
Journal Article
Closed access
IFInes Fonfara
Ines Fonfara
HRHagen Richter
Hagen Richter
MBMajda Bratovič
Majda Bratovič
ARAnaïs Le Rhun
Anaïs Le Rhun
ECEmmanuelle Charpentier
Emmanuelle Charpentier

21 November 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
IFInes Fonfara
Ines Fonfara
ARAnaïs Le Rhun
Anaïs Le Rhun
KCKrzysztof Chylinski
Krzysztof Chylinski
KMKira S. Makarova
Kira S. Makarova
ALAnne-Laure Lécrivain
Anne-Laure Lécrivain
ECEmmanuelle Charpentier
Emmanuelle Charpentier
The CRISPR-Cas-derived RNA-guided Cas9 endonuclease is the key element of an emerging promising technology for genome engineering in a broad range of cells and organisms. The DNA-targeting mechanism of the type II CRISPR-Cas system involves maturation of tracrRNA:crRNA duplex (dual-RNA), which directs Cas9 to cleave invading DNA in a sequence-specific manner, dependent on the presence of a Protospacer Adjacent Motif (PAM) on the target. We show that evolution of dual-RNA and Cas9 in bacteria produced remarkable sequence diversity. We selected eight representatives of phylogenetically defined type II CRISPR-Cas groups to analyze possible coevolution of Cas9 and dual-RNA. We demonstrate that these two components are interchangeable only between closely related type II systems when the PAM sequence is adjusted to the investigated Cas9 protein. Comparison of the taxonomy of bacterial species that harbor type II CRISPR-Cas systems with the Cas9 phylogeny corroborates horizontal transfer of the CRISPR-Cas loci. The reported collection of dual-RNA:Cas9 with associated PAMs expands the possibilities for multiplex genome editing and could provide means to improve the specificity of the RNA-programmable Cas9 tool.

7 February 2013 in RNA Biology
Verified
Journal Article
Open access
KCKrzysztof Chylinski
Krzysztof Chylinski
ARAnaïs Le Rhun
Anaïs Le Rhun
ECEmmanuelle Charpentier
Emmanuelle Charpentier
CRISPR-Cas is a rapidly evolving RNA-mediated adaptive immune system that protects bacteria and archaea against mobile genetic elements. The system relies on the activity of short mature CRISPR RNA...

30 December 2016 in mBio
Verified
Journal Article
Open access
PDF file
Ulrike ReschUlrike Resch
Ulrike Resch
JTJames Anthony Tsatsaronis
James Anthony Tsatsaronis
ARAnaïs Le Rhun
Anaïs Le Rhun
GSGerald Stübiger
Gerald Stübiger
MRManfred Rohde
Manfred Rohde
ECEmmanuelle Charpentier
Emmanuelle Charpentier
Export of macromolecules via extracellular membrane-derived vesicles (MVs) plays an important role in the biology of Gram-negative bacteria. Gram-positive bacteria have also recently been reported to produce MVs; however, the composition and mechanisms governing vesiculogenesis in Gram-positive bacteria remain undefined. Here, we describe MV production in the Gram-positive human pathogen group A streptococcus (GAS), the etiological agent of necrotizing fasciitis and streptococcal toxic shock syndrome. M1 serotype GAS isolates in culture exhibit MV structures both on the cell wall surface and in the near vicinity of bacterial cells. A comprehensive analysis of MV proteins identified both virulence-associated protein substrates of the general secretory pathway in addition to “anchorless surface proteins.” Characteristic differences in the contents, distributions, and fatty acid compositions of specific lipids between MVs and GAS cell membrane were also observed. Furthermore, deep RNA sequencing of vesicular RNAs revealed that GAS MVs contained differentially abundant RNA species relative to bacterial cellular RNA. MV production by GAS strains varied in a manner dependent on an intact two-component system, CovRS, with MV production negatively regulated by the system. Modulation of MV production through CovRS was found to be independent of both GAS cysteine protease SpeB and capsule biosynthesis. Our data provide an explanation for GAS secretion of macromolecules, including RNAs, lipids, and proteins, and illustrate a regulatory mechanism coordinating this secretory response. IMPORTANCE Group A streptococcus (GAS) is a Gram-positive bacterial pathogen responsible for more than 500,000 deaths annually. Establishment of GAS infection is dependent on a suite of proteins exported via the general secretory pathway. Here, we show that GAS naturally produces extracellular vesicles with a unique lipid composition that are laden with proteins and RNAs. Interestingly, both virulence-associated proteins and RNA species were found to be differentially abundant in vesicles relative to the bacteria. Furthermore, we show that genetic disruption of the virulence-associated two-component regulator CovRS leads to an increase in vesicle production. This study comprehensively describes the protein, RNA, and lipid composition of GAS-secreted MVs and alludes to a regulatory system impacting this process.

11 March 2019 in RNA Biology
Verified
Journal Article
Open access
ARAnaïs Le Rhun
Anaïs Le Rhun
AEAndrés Escalera-Maurer
Andrés Escalera-Maurer
MBMajda Bratovič
Majda Bratovič
ECEmmanuelle Charpentier
Emmanuelle Charpentier
The discovery and characterization of the prokaryotic CRISPR-Cas immune system has led to a revolution in genome editing and engineering technologies. Despite the fact that most applications emerged after the discovery of the type II-A CRISPR-Cas9 system of Streptococcus pyogenes, its biological importance in this organism has received little attention. Here, we provide a comprehensive overview of the current knowledge about CRISPR-Cas systems from S. pyogenes. We discuss how the interplay between CRISPR-mediated immunity and horizontal gene transfer might have modeled the evolution of this pathogen. We review the current literature about the CRISPR-Cas systems present in S. pyogenes (types I-C and II-A), and describe their distinctive biochemical and functional features. Finally, we summarize the main biotechnological applications that have arisen from the discovery of the CRISPR-Cas9 system in S. pyogenes.

27 June 2019 in Molecular Cell
Verified
Journal Article
Closed access
HRHannah K. Ratner
Hannah K. Ratner
AEAndrés Escalera-Maurer
Andrés Escalera-Maurer
ARAnaïs Le Rhun
Anaïs Le Rhun
SJSiddharth Jaggavarapu
Siddharth Jaggavarapu
JWJessie E. Wozniak
Jessie E. Wozniak
DWDavid Weiss
David Weiss